Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium

CELC Stock  USD 12.46  0.46  3.83%   
About 56% of all Celcuity LLC's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Celcuity LLC suggests that some traders are interested. The current market sentiment, together with Celcuity LLC's historical and current headlines, can help investors time the market. In addition, many technical investors use Celcuity LLC stock news signals to limit their universe of possible portfolio assets.
  
Median overall survival among patients with HR, HER2- advanced breast cancer who were treatment-nave in the advanced setting was 77.3 months Median OS among patients previously treated with a CDK46 inhibitor was 33.9 months MINNEAPOLIS, Dec. 11, 2024 -- Celcuity Inc. , a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced overall survival data from two patient cohorts evaluated in a Phase 1b tri

Read at finance.yahoo.com
Yahoo News
  

Celcuity LLC Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Celcuity LLC can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Celcuity LLC Fundamental Analysis

We analyze Celcuity LLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celcuity LLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celcuity LLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

Celcuity LLC is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Celcuity LLC Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Celcuity LLC stock to make a market-neutral strategy. Peer analysis of Celcuity LLC could also be used in its relative valuation, which is a method of valuing Celcuity LLC by comparing valuation metrics with similar companies.

Peers

Celcuity LLC Related Equities

CCCCC4 Therapeutics   7.92   
0%
73.0%
HOWLWerewolf Therapeutics   7.43   
0%
68.0%
MLYSMineralys Therapeutics,   4.31   
0%
39.0%
RZLTRezolute   3.78   
0%
34.0%
EWTXEdgewise Therapeutics   2.57   
0%
23.0%
ADAGAdagene   1.99   
0%
18.0%
MNOVMediciNova   0.46   
0%
4.0%
ACRVAcrivon Therapeutics,   0.30   
0%
2.0%
CSBRChampions Oncology   0.53   
4.0%
0%
ANTXAN2 Therapeutics   0.79   
7.0%
0%
AVTEAerovate Therapeutics   1.17   
10.0%
0%
MOLNMolecular Partners   2.68   
24.0%
0%
ANABAnaptysBio   3.00   
27.0%
0%
IKNAIkena Oncology   4.32   
39.0%
0%
ANEBAnebulo Pharmaceuticals   10.81   
100.0%
0%

Complementary Tools for Celcuity Stock analysis

When running Celcuity LLC's price analysis, check to measure Celcuity LLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celcuity LLC is operating at the current time. Most of Celcuity LLC's value examination focuses on studying past and present price action to predict the probability of Celcuity LLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celcuity LLC's price. Additionally, you may evaluate how the addition of Celcuity LLC to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Correlations
Find global opportunities by holding instruments from different markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device